A second U.S. citizen has tested positive for Ebola, the CDC reported July 10.
The patient is working as a warehouse manager in the Democratic Republic of Congo for the Christian aid group Samaritan’s Purse and is in his 60s, officials told Reuters in a July 13 report. He was admitted to Frankfurt University Hospital in Germany early July 13. The CDC is working to identify high-risk contacts and conduct contact tracing.
Here are three other things to know:
1. In response to the second Ebola case affecting one of its citizens, the U.S. is advising Americans to “not travel to Congo for any reason.” The alert said travelers exposed to Ebola are required to quarantine outside the country for up to 21 days at their own expense. It did not specify if the guidance applies to humanitarian workers or medical personnel already deployed.
2. As of July 12, confirmed Ebola cases have risen to 1,926 and deaths to 702, resulting in an overall case mortality rate of 36.4%, according to a Congo public health report. There are currently 753 patients in isolation and 318 people have fully recovered. Contact tracing has also risen to 78.3% in two provinces.
3. The U.K. has opened an Bundibugyo Ebola vaccine trial designed to assess its safety and immune response in 50 healthy adults. The trial will test the vaccine known as ChAdOx1 BDBV. It is recruiting volunteers and expects to begin in the next few weeks, Sky News reported July 13.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
